Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1771-1777

  Urbina, Julio A ^a,f   Payares, Gilberto ^b   Contreras, Lellys M ^a   Liendo, Andreína ^a   Sanoja, Cristina ^b   Molina, Judith ^b   Piras, Marta ^c   Piras, Romano ^c   Perez, Norma ^a,d   Wincker, Patrick ^d   Loebenberg, David ^e  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c Centro Medico Docente La Trinidad   (Venezuela)

^d UNIV MONTPELLIER   (France)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CHAGAS DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; GAS CHROMATOGRAPHY; METHYLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0031807492     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1771     Document Type: Article

References (44)

1. Brener, Z., J. R. Cançado, L. M. Galvão, Z. M. P. da Luz, L. de S. Filardi, M. E. S. Pereira, L. M. T. Santos, and C. B. Cançado. 1993. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Mem. Inst. Oswaldo Cruz 88:149-153.
2. Britto, C., M. A. Cardoso, C. M. Monteiro Vanni, A. Hasslocher-Moreno, S. S. Xavier, W. Oelemann, A. Santoro, C. Pirmez, C. M. Morel, and P. Wincker. 1995. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 110:241-247.
3. Britto, C., M. A. Cardoso, P. Wincker, and C. M. Morel. 1993. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease. Mem. Inst. Oswaldo Cruz 88: 171-172.
4. Clemons, K. V., L. H. Hanson, and D. A. Stevens. 1993. Activities of the triazole D0870 in vitro and against murine blastomycosis. Antimicrob. Agents Chemother. 37:1177-1179.
5. Contreras, L. M., J. Vivas, and J. A. Urbina. 1997. Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors. Biochem. Pharmacol. 53:697-704.
6. Croft, S. L., J. A. Urbina, and R. Brun. 1997. Chemotherapy of human leishmaniasis and trypanosomiasis, p. 245-257. In G. Hide, J. C. Mottram, G. H. Coombs, and P. H. Holmes (ed.), Trypanosomiasis and leishmaniasis. CAB International, London, United Kingdom.
7. de Castro, S. L. 1993. The challenge of Chagas disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Trop. 53:83-98.
8. De Maio, A., and J. A. Urbina. 1984. Trypanosoma (Schizotrypanum) cruzi: terminal oxidases in two growth phases in vitro. Acta Cient. Venez. 35:136-141.
9. De Wit, S., E. O'Doherty, R. P. Smith, R. Yates, and N. Clumeck. 1995. Pharmacokinetics of two multiple dosing regimens of D0870 in HIV positive patients: a phase I study, abstr. F97, p. 129. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Filardi, L. S., and Z. Brener. 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used in Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81:755-759.
11. Girijavallabhan, V. M., A. K. Saksena, R. G. Lovey, F. Bennett, R. E. Pike, H. Wang, P. Pinto, Y. T. Liu, N. Patel, and A. K. Ganguly. 1995. SCH 56592, a novel orally active broad spectrum antifungal agent, abstr. F61, p. 123. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Hudson, L., F. Grover, W. E. Gutteridge, R. A. Klein, W. Peters, R. A. Neal, M. A. Miles, M. T. Scott, R. Nourish, and B. P. Ager. 1983. Suggested guidelines for work with live Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 77:416-419.
13. Laughlin, M., S. Pai, S. Menon, A. Nomeir, R. Colucci, M. Affrime, and T. Kosoglou. 1997. SCH 56592: rising multiple-dose safety, tolerance, and pharmacokinetic evaluation in healthy volunteers, abstr. A-87. p. 18. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
14. Lazardi, K., J. A. Urbina, and W. De Souza. 1990. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 34:2097-2105.
15. Lazardi, K., J. A. Urbina, and W. de Souza. 1991. Ultrastructural alterations induced by ICI 195,739, a bis-triazole with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 35:736-740.
16. Liendo, A., K. Lazardi, and J. A. Urbina. 1998. Antiproliferative effects of D0870 on Trypanosoma (Schizotrypanum) cruzi. J. Antimicrob. Chemother. 41:197-205.
17. Maldonado, R. A., J. Molina, G. Payares, and J. A. Urbina. 1993. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrob. Agents Chemother. 37: 1353-1359.
18. McCabe, R. E. 1988. Failure of ketoconazole to cure chronic murine Chagas disease. J. Infect. Dis. 158:1408-1409.
19. McCabe, R. E., J. S. Remington, and F. G. Araujo. 1984. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection against a lethal infection with the organism. J. Infect. Dis. 150:594-601.
20. McCabe, R. E., J. S. Remington, and F. G. Araujo. 1986. In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 35:280-284.
21. McCabe, R. E., J. S. Remington, and F. J. Araujo. 1987. Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 81:613-615.
22. Molina, J. T., M. S. S. Araujo, M. E. S. Pereira, Z. Brener, and J. A. Urbina. 1997. Activity of the bis-triazole D0870 against drug-resistant Trypanosoma cruzi strains, abstr. B-41b, p. 34. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
23. Molina, J., Z. Brener, and J. A. Urbina. Unpublished data.
24. Moreira, A. A. B., H. B. W. T. DeSouza, V. Amato Neto, L. Matsubara, P. L. S. Pinto, J. E. Tolezano, E. V. Nunes, and M. Okumura. 1992. Avaliacão da atividade terapêutica do itraconazol nas infecçoes crônicas, experimental e humana, pelo Trypanosoma cruzi. Rev. Inst. Med. Trop. Sao Paulo 34:177-180.
25. Munayyer, H., K. J. Shaw, R. S. Hare, B. Salisbury, L. Heimark, B. Pramanik, and J. R. Greene. 1996. SCH 56592 is a potent inhibitor of sterol C14 demethylation in fungi, abstr. F92, p. 115. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Nomeir, A., P. Kumari, M. J. Hilbert, D. Loebenberg, A. Cacciapuoti, J. Menzel, Jr., E. Moss, Jr., R. Hare, G. H. Miller, M. N. Cayen, and C. C. Lin. 1995. Comparative pharmacokinetics of a new triazole antifungal agent, SCH 56592, in mice, rats, rabbits, dogs and cynomolgus monkeys, abstr. F68, p. 124. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
27. Perfect, J. R., G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
28. Pfaller, M. A., S. Messer, and R. N. Jones. 1997. Activity of a new triazole, SCH 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 41:233-235.
29. Pfaller, M. A., L. Zerva, S. Messer, and R. N. Jones. 1996. Antifungal activity of a new triazole, SCH 56592, compared with four other antifungal agents tested against clinical isolates of Candida spp., abstr. F87, p. 115. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
30. Quintas, L. E. M., S. L. de Castro, J. A. Urbina, J. A. Borba-Santos, C. N. Pinto, R. Siqueira-Batista, and N. Miranda Filho. 1996. Tratamento da doença de Chagas, p. 125-170. In R. Siqueira-Batista, A. D. Corrêa, and D. W. Higgins (ed.), Molestia de Chagas. Editora Cultura Medica, Rio de Janeiro, Brazil.
31. Rassi A., and A. O. Luquetti. 1992. Therapy of Chagas disease, p. 237-247. In S. Wendel, Z. Brener, M. E. Camargo, and A. Rassi (ed.), Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine. ISBT BRAZIL '92. Cartgraf Editora, São Paulo, Brazil.
32. Ryley, J. F., S. McGregor, and R. G. Wilson. 1988. Activity of ICI 195,739 - a novel orally active bistriazole - in rodent models of fungal and protozoal infections. Ann. N. Y. Acad. Sci. 544:310-328.
33. Sanglard, D., F. Ischer, and J. Bille. 1997. Interaction of the azole SCH56592 with Candida albicans multidrug transporters and different cytochrome P450 forms, abstr. C-11, p. 48. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
34. Sugar, A. M., and X.-P. Liu. 1996. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis. Antimicrob. Agents Chemother. 40:1314-1316.
35. Urbina, J. A. 1997. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites. Parasitology 117:S91-S99.
36. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1988. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 32:1237-1242.
37. Urbina, J. A., K. Lazardi, T. Aguirre, M. M. Piras, and R. Piras. 1991. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob. Agents Chemother. 35:730-735.
38. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, R. A. Maldonado, G. Payares, and W. De Souza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vivo and in vitro studies. Antimicrob. Agents Chemother. 37:580-591.
39. Urbina, J. A., G. Payares, J. Molina, C. Sanoja, A. Liendo, K. Lazardi, M. M. Piras, R. Piras, N. Perez, P. Wincker, and J. F. Ryley. 1996. Cure of short- and long-term experimental Chagas disease using D0870. Science 273:969-971.
40. 24(25) sterol methy transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Chemotherapy (Basel) 42:294-307.
41. 24(25) sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol. Biochem. Parasitol. 73:199-210.
42. Wincker, P., C. Britto, J. Borges-Pereira, M. A. Cardoso, W. Oelemann, and C. M. Morel. 1994. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am. J. Trop. Med. Hyg. 51:771-777.
43. World Development Report. 1993. Investing in health. World Bank.
44. Yarosh-Tomaine, T., H. Munayyer, K. J. Shaw, R. S. Hare, L. Heimark, B. Pramanik, and J. R. Greene. 1996. Studies on fungal resistance to SCH 56592, abstr. F91, p. 115. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.